Live from the NIH registry
Studies recruiting near Memphis right now
Top 25 of 580 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Charles Retina Institute — Germantown, Tennessee (9.0 mi)
· Sponsor: Genentech, Inc.
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Westat
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Memphis, Tennessee (5.5 mi)
· Sponsor: Sameek Roychowdhury
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Stern Cardiovascular — Southaven, Mississippi (8.7 mi)
· Sponsor: Duke University
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Memphis, Tennessee (5.5 mi)
· Sponsor: Daiichi Sankyo
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Dravet Syndrome
Phase 1, Phase 2
Interventional 32 participants sought
Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
The West Clinic, PC dba West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: IceCure Medical Ltd.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
West Cancer Center and Research Institute ( Site 0055) — Germantown, Tennessee (9.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Papillary Thyroid Cancer, Pediatric Cancer
N/A
Observational 32 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Children's Hospital of Philadelphia
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Semmes Murphey Foundation — Memphis, Tennessee (5.5 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Baptist Clinical Research Institute — Memphis, Tennessee (5.5 mi)
· Sponsor: Kura Oncology, Inc.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
The West Clinic, PLLC dba West Cancer Center — Germantown, Tennessee (9.0 mi)
· Sponsor: Pfizer
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: St. Jude Children's Research Hospital
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial
Childhood Cancer Survivor, Chronic Pain
N/A
Interventional 116 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: St. Jude Children's Research Hospital
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2
Interventional 90 participants sought
NACHO Consortium — Memphis, Tennessee (5.5 mi)
· Sponsor: Carl Allen
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
Neurology Clinical, P.C. — Cordova, Tennessee (11.2 mi)
· Sponsor: AC Immune SA
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi)
· Sponsor: NRG Oncology
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Baptist Memorial Hospital and Cancer Center-Memphis — Memphis, Tennessee (5.5 mi)
· Sponsor: NRG Oncology
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Aviati Health — Memphis, Tennessee (5.5 mi)
· Sponsor: Coologics, Inc
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
Sarcoma, Childhood Osteosarcoma
Phase 1
Interventional 42 participants sought
St. Jude Children's Research Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: St. Jude Children's Research Hospital
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Carcinoma, Renal Cell
Phase 3
Interventional 758 participants sought
The West Clinic, P.C. ( Site 0115) — Germantown, Tennessee (9.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Le Bonheur Children's Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: Children's Hospital of Philadelphia
Pregnancies Complicated by Fetal Anomalies
Pregnancy, Congenital Abnormalities
N/A
Observational 500 participants sought
LeBonheur Children's Hospital — Memphis, Tennessee (5.5 mi)
· Sponsor: University of Tennessee